#ITI#Neurological manifestations of avian influenza viruses in mammals#FTI#
#IRE#The H5N1 viruses isolated from humans in Hong Kong directly infected both mice and ferrets without prior adaptation to either host. Two representative viruses, A/Hong Kong/483/97 (HK/483) and A/Hong Kong/486/97 (HK/486) were equally virulent in outbred ferrets but differed in their virulence in inbred mice. Both HK/483 and HK/486 replicated systemically in ferrets and showed neurologic manifestations. In contrast, intranasal infection of mice with HK/483, but not HK/486, resulted in viral spread to the brain, neurologic signs, and death. However, HK/486 was able to replicate in the brain and induce lethal disease following direct intracerebral inoculation.#FRE#
#IPC#Avian influenza; Ferret; H5N1; Mouse; Neurovirulence#FPC#
#IRF#Campbell D., Sweet C., Smith H., Comparisons of virulence of influenza virus recombinants in ferrets in relation to their behavior in man and their genetic constitution, Infect. Immunol., 21, pp. 221-228, (1979); 
Class E.C.J., Osterhaus A.D.M.E., Van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., Webster R.G., Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus, Lancet, 351, pp. 472-477, (1998); 
De Jong J.C., Claas E.C.J., Osterhaus A.D.M.E., Webster R.G., Lim W.L., A pandemic warning, Nature, 389, (1998); 
Gao P., Watanabe S., Ito T., Goto H., Wells K., McGregor M., Cooley A.J., Kawaoka Y., Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from Hong Kong, J. Virol., 73, pp. 3184-3189, (1999); 
Katz J.M., Lu X., Tumpey T.M., Smith C.B., Shaw M.W., Subbarao K., Molecular correlates of influenza A H5N1 virus pathogenesis in mice, J. Virol., 74, pp. 807-810, (2000); 
Lu X., Tumpey T.M., Morken T., Zaki S.R., Cox N.J., Katz J.M., A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans, J. Virol., 73, pp. 5903-5911, (1999); 
Maassab H.F., Kendal A.P., Abrams G.D., Monto A.S., Evaluation of a cold-recombinant influenza virus vaccine in ferrets, J. Infect. Dis., 146, pp. 780-790, (1982); 
Reed L.J., Muench H., A simple method for estimating fifty percent endpoints, Am. J. Hyg., 27, pp. 493-497, (1938); 
Rowe T., Biocontainment of highly pathogenic avian influenza viruses, Anthology of Biosafety, Vol. II - Facility Design Considerations, 2, pp. 16-34, (2000); 
Senne D.A., Panigrapy B., Kawaoka Y., Pearson J.E., Suss J., Lipkind M., Kida H., Webster R.G., Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential, Avian Dis., 40, pp. 425-437, (1996); 
Shortridge K.F., Zhou N.N., Guan Y., Gao P., Ito T., Kawaoka Y., Kodihalli S., Krauss S., Markwell D., Murti K.G., Norwood M., Senne D., Sims L., Takada A., Webster R.G., Characterization of avian H5N1 influenza viruses from poultry in Hong Kong, Virology, 252, pp. 331-342, (1998); 
Sidwell R.W., The mouse model of influenza virus infection, Handbook of Animal Models of Infection, pp. 981-987, (1999); 
Smith H., Sweet C., Lessons for human influenza from pathogenicity studies with ferrets, Rev. Infect. Dis., 10, pp. 56-75, (1988); 
Suarez D.L., Perdue M.L., Cox N.J., Rowe T., Bender C., Huang J., Swayne D.E., Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong, J. Virol., 72, pp. 6678-6688, (1998); 
Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne C., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox J., Characterization of an avian influenza (H5N1) virus isolated from a child with fatal respiratory illness, Science, 279, pp. 393-396, (1998); 
Sweet C., Fenton R.J., Price G.E., The ferret as an animal model of influenza virus infection, Handbook of Animal Models of Infection, pp. 989-998, (1999); 
Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M., Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans, J. Virol., 74, pp. 1443-1450, (2000); 
Yuen K.Y., Chan P.K., Peiris M., Tsang D.N.C., Que T.L., Shortridge K.F., Cheung P.T., To W.K., Ho E.T.F., Sung R., Cheng A.F.B., Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus, Lancet, 351, pp. 467-471, (1998); 
Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt E., Miller G.L., Khan A.S., Rollin P.E., Ksiazek T.G., Nichol S.T., Mahy B.W., Peters C.J., Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease, Am. J. Pathol., 146, pp. 552-579, (1995); 
Zambon M., Laboratory containment for influenza A H5N1 viruses: Level 2, level 3, or level 3 + ?, Comm. Dis. Public Health, 1, pp. 71-72, (1998); 
Zitzow L.A., Rowe T., Morken T., Shieh W., Zaki S., Katz J.M., Pathogenesis of avian influenza A (H5N1) viruses in ferrets, J. Virol., 76, pp. 4420-4429, (2002)#FRF#
